Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic Use of Extracellular Vesicles for Acute and Chronic Lung Disease
Erin N. Worthington, James S. Hagood
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 7, pp. 2318-2318
Open Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

New Insights into Pathomechanisms and Treatment Possibilities for Lung Silicosis
Jana Adamčáková, Daniela Mokrá
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 4162-4162
Open Access | Times Cited: 118
Technological advances towards extracellular vesicles mass production
Alice Grangier, Julien Branchu, Jeanne Volatron, et al.
Advanced Drug Delivery Reviews (2021) Vol. 176, pp. 113843-113843
Open Access | Times Cited: 105
Understanding exosomes: Part 2—Emerging leaders in regenerative medicine
Richard J. Miron, Nathan E. Estrin, Anton Sculean, et al.
Periodontology 2000 (2024) Vol. 94, Iss. 1, pp. 257-414
Open Access | Times Cited: 16
International Society for Extracellular Vesicles and International Society for Cell and Gene Therapy statement on extracellular vesicles from mesenchymal stromal cells and other cells: considerations for potential therapeutic agents to suppress coronavirus disease-19
Verena Börger, Daniel J. Weiss, Johnathon D. Anderson, et al.
Cytotherapy (2020) Vol. 22, Iss. 9, pp. 482-485
Open Access | Times Cited: 115
Mesenchymal stem cells and exosome therapy for COVID-19: current status and future perspective
Ashim Gupta, Shivaji Kashte, Manu Gupta, et al.
Human Cell (2020) Vol. 33, Iss. 4, pp. 907-918
Open Access | Times Cited: 73
Engineered Extracellular Vesicles Derived from Dermal Fibroblasts Attenuate Inflammation in a Murine Model of Acute Lung Injury
Ana I. Salazar‐Puerta, María A. Rincon‐Benavides, Tatiana Z. Cuellar‐Gaviria, et al.
Advanced Materials (2023) Vol. 35, Iss. 28
Open Access | Times Cited: 39
Therapeutic potential of mesenchymal stem/stromal cell-derived secretome and vesicles for lung injury and disease
Airan Liu, Xiwen Zhang, Hongli He, et al.
Expert Opinion on Biological Therapy (2019) Vol. 20, Iss. 2, pp. 125-140
Open Access | Times Cited: 74
Diverse Effects of Exosomes on COVID-19: A Perspective of Progress From Transmission to Therapeutic Developments
Sangiliyandi Gurunathan, Min-Hee Kang, Jin‐Hoi Kim
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 53
Mesenchymal stromal cell extracellular vesicles as therapy for acute and chronic respiratory diseases: A meta‐analysis
Alvin Tieu, Kevin Hu, Catherine Gnyra, et al.
Journal of Extracellular Vesicles (2021) Vol. 10, Iss. 12
Open Access | Times Cited: 51
Stem Cell Therapy Potency in Personalizing Severe COVID-19 Treatment
Arefeh Basiri, Fatemeh Mansouri, Arezo Azari, et al.
Stem Cell Reviews and Reports (2021) Vol. 17, Iss. 1, pp. 193-213
Open Access | Times Cited: 45
Mesenchymal Stem Cell-Derived Extracellular Vesicles for Therapeutic Use and in Bioengineering Applications
Caroline McLaughlin, Pallab Datta, Yogendra Pratap Singh, et al.
Cells (2022) Vol. 11, Iss. 21, pp. 3366-3366
Open Access | Times Cited: 28
Exploring the role of polymers to overcome ongoing challenges in the field of extracellular vesicles
Laurianne Simon, Vincent Lapinte, Marie Morille
Journal of Extracellular Vesicles (2023) Vol. 12, Iss. 12
Open Access | Times Cited: 17
Extracellular Vesicle‐Inspired Therapeutic Strategies for the COVID‐19
Ziwei Hu, Wei Wang, Ying Lin, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 29
Closed Access | Times Cited: 7
Therapeutic utility of human umbilical cord-derived mesenchymal stem cells-based approaches in pulmonary diseases: Recent advancements and prospects
Min Meng, Weiwei Zhang, Shuangfeng Chen, et al.
World Journal of Stem Cells (2024) Vol. 16, Iss. 2, pp. 70-88
Open Access | Times Cited: 6
Extracellular vesicles from mesenchymal stem cells as a Covid-19 treatment
Lorraine O’Driscoll
Drug Discovery Today (2020) Vol. 25, Iss. 7, pp. 1124-1125
Open Access | Times Cited: 49
Clinical Applications of Mesenchymal Stem/Stromal Cell Derived Extracellular Vesicles: Therapeutic Potential of an Acellular Product
Margherita Massa, Stefania Croce, Rita Campanelli, et al.
Diagnostics (2020) Vol. 10, Iss. 12, pp. 999-999
Open Access | Times Cited: 46
Updates on clinical trials evaluating the regenerative potential of allogenic mesenchymal stem cells in COVID-19
Dhavan Sharma, Feng Zhao
npj Regenerative Medicine (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 36
PRDX1 negatively regulates bleomycin-induced pulmonary fibrosis via inhibiting the epithelial-mesenchymal transition and lung fibroblast proliferation in vitro and in vivo
Hu‐Nan Sun, Chenxi Ren, Dong Hun Lee, et al.
Cellular & Molecular Biology Letters (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 15
Beyond Macromolecules: Extracellular Vesicles as Regulators of Inflammatory Diseases
Kaushik Das, Subhojit Paul, Tanmoy Mukherjee, et al.
Cells (2023) Vol. 12, Iss. 15, pp. 1963-1963
Open Access | Times Cited: 14
Therapeutic Potential of Exosomes in Pulmonary Fibrosis
Linshen Xie, Ye Zeng
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 33
Therapeutic Potential of Mesenchymal Stem Cells and Their Products in Lung Diseases—Intravenous Administration versus Inhalation
Eleonore Fröhlich
Pharmaceutics (2021) Vol. 13, Iss. 2, pp. 232-232
Open Access | Times Cited: 32
Extracellular Vesicles as Potential Therapeutics for Inflammatory Diseases
Hee Sook Hwang, Hyo‐Suk Kim, Geonhee Han, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5487-5487
Open Access | Times Cited: 30
Exosomes contribution in COVID-19 patients’ treatment
Loubna Mazini, Luc Rochette, Gabriel Malka
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 30
Therapeutic Potential for Regulation of the Nuclear Factor Kappa-B Transcription Factor p65 to Prevent Cellular Senescence and Activation of Pro-Inflammatory in Mesenchymal Stem Cells
Rocío Mato-Basalo, Miriam Morente-López, Onno J. Arntz, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3367-3367
Open Access | Times Cited: 28
Mesenchymal stromal/stem cells (MSCs) and MSC-derived extracellular vesicles in COVID-19-induced ARDS: Mechanisms of action, research progress, challenges, and opportunities
Susan Moradinasab, Atieh Pourbagheri‐Sigaroodi, Parisa Zafari, et al.
International Immunopharmacology (2021) Vol. 97, pp. 107694-107694
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top